Home / Inspections / 1049028

FDA Inspection 1049028 — Geisinger Medical Center Blood Bank

Geisinger Medical Center Blood Bank — FEI 2571086

The FDA completed an inspection of Geisinger Medical Center Blood Bank on April 3, 2018 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Danville, PA (United States)

Facility

Other inspections at this facility

  • 1119128 (NAI Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1077348 (NAI Thu Jan 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993518 (NAI Wed Nov 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 971865 (NAI Wed May 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 902585 (NAI Thu Nov 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources